Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 1
2007 1
2008 1
2009 1
2010 3
2011 1
2012 1
2013 2
2014 4
2015 15
2016 18
2017 17
2018 13
2019 8
2020 21
2021 24
2022 21
2023 6
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next.
Stahl A, Nakanishi H, Lepore D, Wu WC, Azuma N, Jacas C, Vitti R, Athanikar A, Chu K, Iveli P, Zhao F, Leal S, Schlief S, Schmelter T, Miller T, Köfüncü E, Fielder A; FIREFLEYE next Study Group. Stahl A, et al. JAMA Netw Open. 2024 Apr 1;7(4):e248383. doi: 10.1001/jamanetworkopen.2024.8383. JAMA Netw Open. 2024. PMID: 38687481 Free PMC article. Clinical Trial.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Feb 19:S0161-6420(24)00134-9. doi: 10.1016/j.ophtha.2024.02.014. Online ahead of print. Ophthalmology. 2024. PMID: 38382813 Free article.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2023 Dec 28:S0161-6420(23)00933-8. doi: 10.1016/j.ophtha.2023.12.026. Online ahead of print. Ophthalmology. 2023. PMID: 38158159 Free article.
Bilateral evolution of OCT biomarkers in dry AMD: Long-term follow up study.
Samanta A, Arora S, Jhingan M, Singh S, Amarasekera S, Tucci D, Cagini C, Lupidi M, Chhablani J. Samanta A, et al. Among authors: cagini c. Eur J Ophthalmol. 2024 May;34(3):683-690. doi: 10.1177/11206721231204383. Epub 2023 Oct 3. Eur J Ophthalmol. 2024. PMID: 37787166
Cardiolipin-mediated temporal response to hydroquinone toxicity in human retinal pigmented epithelial cell line.
Davidescu M, Mezzasoma L, Fettucciari K, Pascucci L, Pariano M, Di Michele A, Bereshchenko O, Cagini C, Cellini B, Corazzi L, Bellezza I, Macchioni L. Davidescu M, et al. Among authors: cagini c. Biochim Biophys Acta Mol Cell Res. 2023 Dec;1870(8):119554. doi: 10.1016/j.bbamcr.2023.119554. Epub 2023 Jul 30. Biochim Biophys Acta Mol Cell Res. 2023. PMID: 37524263 Free article.
New insights on circumscribed choroidal hemangioma: "bench to bedside".
Lupidi M, Centini C, Castellucci G, Nicolai M, Lassandro N, Cagini C, Rizzo C, Chhablani J, Mariotti C. Lupidi M, et al. Among authors: cagini c. Graefes Arch Clin Exp Ophthalmol. 2024 Apr;262(4):1093-1110. doi: 10.1007/s00417-023-06179-x. Epub 2023 Jul 28. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37505277 Free PMC article. Review.
134 results